通过PROTACs向降解BRD4:癌症治疗的进展
Yanyun Hong1, Xiang Liu1, Yinglong Li1
1Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013, Jiangxi, China. shanxu9891@126.com.
Chemical communications (Cambridge, England)
|February 4, 2026
概括
化向的仿真体 (PROTACs) 提供了一种新的方法来降解BRD4,这是癌症的关键驱动因素. 这项技术旨在克服传统抑制剂的局限性,以改善癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 含基多马因的蛋白4 (BRD4) 是各种癌症中显著的致癌驱动因素.
- 现有的BRD4抑制剂面临挑战,包括耐药性,毒性和低同型选择性.
- 化向化明体 (PROTAC) 技术为向蛋白质降解提供了一个有希望的替代方案.
研究的目的:
- 在过去十年中,审查了针对BRD4的PROTAC用于癌症治疗的进展.
- 探索优化三元复杂设计,生物直角激活和BRD4 PROTACs传递系统的策略.
- 突出PROTACs在克服传统BRD4抑制剂的局限性的潜力.
主要方法:
- 对针对BRD4的PROTACs的文献进行系统审查.
- 分析PROTAC设计策略,包括连接体集成 (JQ1,ABBV-075,HJB97),宏循环化和双重定位.
- 检查生物对等激活方法 (照片封装,化学诱导) 和精确传递系统 (抗体-PROTACs,叶酸-PROTACs).
主要成果:
- 通过招募BRD4和E3酶 (CRBN,VHL,MDM2,DCAF),PROTACs通过无素-蛋白酶系统诱导BRD4的降解.
- 优化的 PROTAC 设计,包括宏循环化和双重定位,增强功效和异型选择性.
- 生物对角激活和先进的输送系统减轻了目标外毒性,提高了治疗精度.
结论:
- 向BRD4的PROTACs代表了癌症治疗的重大进步,提供向降解瘤原因驱动因素.
- 对PROTACs的多维优化正在推动它们的临床转化.
- 这些新型降解剂承诺更安全,更有效,更精确地控制癌症治疗策略.
相关概念视频
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
02:58Regulated Protein Degradation
8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
02:58Regulated Protein Degradation
3.2K
3.2K
02:11Proteins: From Genes to Degradation
14.5K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
14.5K
02:11Proteins: From Genes to Degradation
4.5K
4.5K